サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1784158

空間オミックスの世界市場

Spatial OMICS

出版日
ページ情報
英文 228 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
空間オミックスの世界市場
出版日: 2025年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 228 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

空間オミックスの世界市場は2030年までに20億米ドルに達する見込み

2024年に7億6,770万米ドルと推定される空間オミックスの世界市場は、分析期間2024-2030年にCAGR 17.5%で成長し、2030年には20億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである空間トランスクリプトミクスは、CAGR 19.1％を記録し、分析期間終了までに13億米ドルに達すると予測されます。空間ゲノミクス分野の成長率は、分析期間でCAGR 14.8％と推定されます。

米国市場は2億180万米ドルと推定、中国はCAGR16.5％で成長予測

米国の空間オミックス市場は、2024年に2億180万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR16.5%を牽引し、2030年には3億1,040万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ16.4％と15.0％と予測されています。欧州では、ドイツがCAGR約12.7%で成長すると予測されています。

世界の空間オミックス市場- 主要動向と促進要因のまとめ

なぜ空間オミックスが分子細胞生物学の未来を変えるのか？

空間オミックスは、生命科学と生物医学研究において、分子活動をその本来の空間的背景の中でマッピングする前例のない能力を提供し、変革をもたらす力として急速に台頭しています。高解像度イメージング、トランスクリプトミクス、プロテオミクス、メタボロミクスを空間情報と組み合わせることで、研究者は遺伝子発現やタンパク質相互作用が組織構造や微小環境にわたってどのように変化するかを調査できるようになりました。この統合されたアプローチは、空間的位置づけを欠くバルクシーケンスやシングルセルシーケンスを大きく飛躍させるものです。空間オミックスにより、科学者は組織の不均一性、疾患の進行、細胞間コミュニケーションの複雑さを精緻に解明することができます。腫瘍学、神経科学、免疫学、発生生物学における応用は、研究者が単にどの遺伝子が発現しているかだけでなく、それらが組織マトリックス内のどこでどのように相互作用しているかを理解することを目指しているため、急速に拡大しています。特にがん研究では、腫瘍断端の描出、免疫細胞浸潤の追跡、治療効果に影響を与える微小環境ニッチの同定に空間オミックスが役立っています。ライフサイエンスが精密医療をさらに推し進める中で、空間オミックスは標的治療、バイオマーカー探索、次世代診断の重要な実現者として際立っています。

技術革新は空間オミックスの解像度とアクセシビリティをどのように高めていますか？

空間オミックスの分野は、イメージング・プラットフォーム、分子標識、バーコード戦略、データ解析における急速な技術革新によって推進されています。蛍光in situハイブリダイゼーション（FISH）、免疫組織化学、次世代シークエンシングを組み合わせたハイスループットプラットフォームは、現在では一つの組織切片内で数百から数千のRNA転写物やタンパク質を同時に可視化することが可能です。空間トランスクリプトミクス、多重イオンビームイメージング（MIBI）、seqFISH、CODEXなどの技術は、2Dと3Dの両方の組織ランドスケープにわたって、スケーラブルなソリューションを研究者に提供しています。新しい化学主導のワークフローは、低存在量の分子をより高い感度で検出することを可能にし、先進的なマイクロ流体工学とナノ加工技術は、細胞内レベルまで空間分解能を高めています。AIと機械学習もまた、複雑な空間データセットの分析においてますます重要な役割を果たすようになっており、以前は複雑すぎて解明できなかった空間パターンや生体分子ネットワークの解釈を可能にしています。エピゲノミクスやメタボロミクスなど、他のオミックス層との統合は、空間解析の奥行きをさらに広げ、細胞機能、分化、疾患病態に関する多次元的な洞察をもたらしています。このような技術的進歩により、空間オミックスはよりロバストで再現性が高く、ユーザーフレンドリーなものとなり、研究室や臨床機関の幅広い層に利用されるようになっています。

市場の需要が最も急速に高まっている場所と、主要なエンドユーザーは？

空間オミックステクノロジーは、学術、製薬、バイオテクノロジー、臨床研究の各分野で支持を集めています。学術機関では、研究者が空間解析を活用して、脳回路、胚発生、組織再生を単一細胞レベルで研究しています。製薬会社やバイオテクノロジー企業は、創薬やトランスレーショナルリサーチ、特に腫瘍学において、腫瘍微小環境を理解することが免疫ベースの治療法や標的介入の開発に不可欠であるため、空間オミックスを導入しています。開発業務受託機関（CRO）もまた、空間オミックスをバイオマーカー開発パイプラインに統合し、空間的に分解されたデータセットを追求する顧客に特化したサービスを提供しています。病院や診断ラボは、空間オミックスを病理学や個別化医療における将来のツールとして、特に希少疾患や従来の治療に反応しない腫瘍のサブタイプを特徴付けるために、検討し始めています。需要は、研究資金や精密医療への取り組みが盛んな米国や欧州で特に高いが、アジア太平洋地域も急速に追い上げており、中国、日本、韓国では空間生物学のインフラ整備に大規模な投資が行われています。プライベートエクイティやベンチャーキャピタルによる空間オミックス新興企業やプラットフォーム開発企業への投資は、技術革新と商業的拡大をさらに促進しています。このように、空間オミックスは、ライフサイエンス業界における基盤技術として確立しつつあります。

空間オミックス市場の長期的成長の原動力は？

空間オミックス市場の成長は、空間的に解像された生物学的データに対する需要の高まり、個別化医療の進化、技術的収束を中心としたいくつかの重要な要因によって牽引されています。特に、がん、神経変性、自己免疫疾患などの異質な疾患メカニズムを理解するためには、空間的コンテキストが不可欠であるという認識が高まっていることが、最も大きな促進要因の一つです。この洞察は、様々な組織タイプや病態にわたって実用的な空間データを提供するツールやプラットフォームへの投資に拍車をかけています。ワークフローの自動化、スケーラビリティ、マルチプレクシングの改善とともに、シーケンシングとイメージング技術の進歩は、コストと複雑さの障壁を減らし、エリート研究センター以外での幅広い採用を可能にしています。アカデミアと産業界との共同開発が進み、特に診断、コンパニオン・バイオマーカー開発、治療反応モニタリングの領域において、空間的発見の臨床応用への転換が加速しています。規制機関や資金提供機関も空間オミックスの可能性を認識し、臨床への統合に向けた助成金や承認を行っています。さらに、空間データセットの拡大は、研究の横断的比較や機械学習アプリケーションを強化する空間アトラスやマルチオミックデータベースの開発を後押ししています。高解像度の生物学的洞察に対するニーズが分野横断的に高まり続ける中、空間オミックスは次世代生物医学研究とプレシジョン・ヘルスケアの基礎となる柱となる位置づけにあります。

セグメント

テクノロジー（空間トランスクリプトミクス、空間ゲノミクス、空間プロテオミクス）、製品（装置、消耗品、ソフトウェア）、ワークフロー（サンプル調製、装置分析、データ分析）、サンプルタイプ（FFPE、新鮮凍結）、エンドユーザー（学術・トランスレーショナルリサーチ機関、製薬・バイオテクノロジー企業）

調査対象企業の例

  • 10x Genomics
  • Agilent Technologies Inc.
  • Akoya Biosciences Inc.
  • Biognosys AG
  • Bio-Rad Laboratories Inc.
  • BioSpyder Technologies
  • Bio-Techne Corporation
  • Bruker Corporation
  • Curio Bioscience
  • Diagenode Diagnostics
  • Illumina Inc.
  • Indica Labs Inc.
  • IonPath Inc.
  • Luminex Corporation
  • Miltenyi Biotec
  • Miroculus Inc.
  • NanoString Technologies Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc.
  • Pixelgen Technologies
  • RareCyte Inc.
  • Rebus Biosystems
  • S2 Genomics Inc.
  • Seven Bridges Genomics
  • Standard BioTools（formerly Fluidigm）
  • Takara Bio Inc.
  • Ultivue Inc.
  • Visiopharm A/S
  • Vizgen Corporation
  • ZEISS Group

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMにクエリーする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP33026

Global Spatial OMICS Market to Reach US$2.0 Billion by 2030

The global market for Spatial OMICS estimated at US$767.7 Million in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 17.5% over the analysis period 2024-2030. Spatial Transcriptomics, one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Spatial Genomics segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$201.8 Million While China is Forecast to Grow at 16.5% CAGR

The Spatial OMICS market in the U.S. is estimated at US$201.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$310.4 Million by the year 2030 trailing a CAGR of 16.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.4% and 15.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Spatial OMICS Market - Key Trends & Drivers Summarized

Why Is Spatial OMICS Reshaping the Future of Molecular and Cellular Biology?

Spatial OMICS is rapidly emerging as a transformative force in life sciences and biomedical research, offering an unprecedented ability to map molecular activity within its native spatial context. By combining high-resolution imaging, transcriptomics, proteomics, and metabolomics with spatial information, researchers can now investigate how gene expression and protein interactions vary across tissue architecture and microenvironments. This integrated approach is a significant leap beyond bulk and single-cell sequencing, which lack spatial positioning. Spatial OMICS is allowing scientists to unravel the complexities of tissue heterogeneity, disease progression, and cell-to-cell communication with exquisite precision. Applications in oncology, neuroscience, immunology, and developmental biology are rapidly expanding, as researchers aim to understand not just what genes are expressed, but where and how they interact within the tissue matrix. Particularly in cancer research, spatial OMICS is helping to delineate tumor margins, track immune cell infiltration, and identify microenvironmental niches that influence treatment response. As life sciences push further into precision medicine, spatial OMICS stands out as a critical enabler of targeted therapies, biomarker discovery, and next-generation diagnostics.

How Are Technology Innovations Elevating the Resolution and Accessibility of Spatial OMICS?

The field of spatial OMICS is being driven forward by rapid innovation in imaging platforms, molecular labeling, barcoding strategies, and data analytics. High-throughput platforms combining fluorescence in situ hybridization (FISH), immunohistochemistry, and next-generation sequencing are now capable of visualizing hundreds to thousands of RNA transcripts and proteins simultaneously within a single tissue section. Technologies such as spatial transcriptomics, multiplexed ion beam imaging (MIBI), seqFISH, and CODEX are providing researchers with scalable solutions across both 2D and 3D tissue landscapes. New chemistry-driven workflows are making it possible to detect low-abundance molecules with greater sensitivity, while advanced microfluidics and nanofabrication techniques are enhancing spatial resolution down to subcellular levels. AI and machine learning are also playing an increasingly vital role in analyzing complex spatial datasets, enabling the interpretation of spatial patterns and biomolecular networks that were previously too intricate to resolve. Integration with other omics layers-such as epigenomics and metabolomics-is further extending the depth of spatial analysis, providing multi-dimensional insights into cell function, differentiation, and disease pathology. These technical advancements are making spatial OMICS more robust, reproducible, and user-friendly, opening access to a broader segment of research labs and clinical institutions.

Where Is Market Demand Emerging Most Rapidly, and Who Are the Key End Users?

Spatial OMICS technologies are gaining traction across academic, pharmaceutical, biotechnology, and clinical research settings. In academic institutions, researchers are leveraging spatial analysis to study brain circuitry, embryonic development, and tissue regeneration at a single-cell level. Pharmaceutical and biotech companies are deploying spatial OMICS for drug discovery and translational research, particularly in oncology, where understanding the tumor microenvironment is crucial to developing immune-based therapies and targeted interventions. Contract research organizations (CROs) are also integrating spatial OMICS into biomarker development pipelines, offering specialized services for clients pursuing spatially resolved datasets. Hospitals and diagnostic labs are beginning to explore spatial OMICS as a future tool in pathology and personalized medicine, especially for characterizing rare diseases or tumor subtypes that don’t respond to conventional treatments. Demand is particularly high in the United States and Europe, where research funding and precision medicine initiatives are strong, but Asia-Pacific is rapidly catching up, with major investments in spatial biology infrastructure across China, Japan, and South Korea. Private equity and venture capital investment in spatial OMICS startups and platform developers is further fueling innovation and commercial expansion. These converging forces are establishing spatial OMICS as a cornerstone technology across the life sciences landscape.

What’s Driving the Long-term Growth of the Spatial OMICS Market?

The growth in the spatial OMICS market is driven by several critical factors centered around the rising demand for spatially resolved biological data, the evolution of personalized medicine, and technological convergence. One of the foremost drivers is the growing realization that spatial context is essential for understanding disease mechanisms, particularly in heterogeneous conditions such as cancer, neurodegeneration, and autoimmune disorders. This insight is fueling investment in tools and platforms that provide actionable spatial data across various tissue types and disease states. The advancement of sequencing and imaging technologies, along with improvements in workflow automation, scalability, and multiplexing, is reducing cost and complexity barriers, enabling wider adoption beyond elite research centers. Increasing collaborations between academia and industry are accelerating the translation of spatial discoveries into clinical applications, particularly in the realm of diagnostics, companion biomarker development, and therapeutic response monitoring. Regulatory agencies and funding bodies are also recognizing the potential of spatial OMICS, directing grants and approvals toward its clinical integration. Additionally, the expansion of spatial datasets is powering the development of spatial atlases and multi-omic databases that enhance cross-study comparisons and machine learning applications. As the need for high-resolution biological insights continues to rise across disciplines, spatial OMICS is positioned to become a foundational pillar of next-generation biomedical research and precision healthcare.

SCOPE OF STUDY:

The report analyzes the Spatial OMICS market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics); Product (Instruments, Consumables, Software); Workflow (Sample Preparation, Instrumental Analysis, Data Analysis); Sample Type (FFPE, Fresh Frozen); End-Use (Academic & Translational Research Institutes, Pharma & Biotech Companies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • 10x Genomics
  • Agilent Technologies Inc.
  • Akoya Biosciences Inc.
  • Biognosys AG
  • Bio-Rad Laboratories Inc.
  • BioSpyder Technologies
  • Bio-Techne Corporation
  • Bruker Corporation
  • Curio Bioscience
  • Diagenode Diagnostics
  • Illumina Inc.
  • Indica Labs Inc.
  • IonPath Inc.
  • Luminex Corporation
  • Miltenyi Biotec
  • Miroculus Inc.
  • NanoString Technologies Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc.
  • Pixelgen Technologies
  • RareCyte Inc.
  • Rebus Biosystems
  • S2 Genomics Inc.
  • Seven Bridges Genomics
  • Standard BioTools (formerly Fluidigm)
  • Takara Bio Inc.
  • Ultivue Inc.
  • Visiopharm A/S
  • Vizgen Corporation
  • ZEISS Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Spatial OMICS - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Explosive Growth in Single-cell Biology Throws the Spotlight on Spatial OMICS as the Next Frontier in Tissue-level Resolution
    • Rising Focus on Tumor Microenvironment Characterization Spurs Adoption of Spatial Transcriptomics in Cancer Research
    • Here's How Precision Medicine Initiatives Expand the Addressable Market for Spatially Resolved Multi-omic Platforms
    • Integration of Spatial Genomics and Proteomics Strengthens the Business Case for Holistic Tissue Analysis Tools
    • Demand for High-resolution Mapping of Cellular Architecture Drives Innovation in Spatial Imaging and Label-free Detection
    • Here's the Story: Spatial OMICS Emerges as a Critical Enabler in Drug Discovery, Target Validation, and Biomarker Development
    • Advancements in In Situ Sequencing and Multiplexed Imaging Propel Growth of Scalable, High-throughput Spatial Platforms
    • AI and Machine Learning Integration Enhances Spatial Data Interpretation and Accelerates Biological Insight Generation
    • Rising Investment by Biopharma in Oncology, Neuroscience, and Immunology Applications Drives Commercial Uptake of Spatial OMICS
    • Emergence of Cloud-based Bioinformatics Solutions Unlocks Opportunities for Scalable Spatial Data Storage and Analysis
    • Growing Demand for Spatial Resolution in FFPE-compatible Assays Expands Clinical Research and Diagnostic Use Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Spatial OMICS Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Spatial OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Spatial OMICS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Spatial Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Spatial Transcriptomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Spatial Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Spatial Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spatial Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Spatial Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for FFPE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for FFPE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Fresh Frozen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Fresh Frozen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic & Translational Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Academic & Translational Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instrumental Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Instrumental Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • JAPAN
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • CHINA
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • EUROPE
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Spatial OMICS by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • FRANCE
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 82: France Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • GERMANY
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • ITALY
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • UNITED KINGDOM
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 112: UK Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: UK 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 114: UK Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 142: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Rest of World 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 144: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Rest of World 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030

IV. COMPETITION